
Please try another search
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company’s pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Name | Age | Since | Title |
---|---|---|---|
Scott Styles | - | - | Member of Antibody Drug Conjugate (ADC) Advisory Board |
Brenda Weigel | - | - | Member of Scientific & Medical Advisory Board |
Meenakshi Hegde | - | - | Member of Scientific & Medical Advisory Board |
John Ciccio | 51 | 2020 | Independent Director |
Nabil M. Ahmed | - | - | Member of Scientific & Medical Advisory Board |
Paul A. Romness | 58 | 2018 | Founder, Chairman, President & CEO |
Jutta Wanner | - | - | Member of Antibody Drug Conjugate (ADC) Advisory Board |
Alejandro Sweet-Cordero | - | - | Member of Scientific & Medical Advisory Board |
Felasfa Mulugeta Wodajo | - | - | Member of Scientific & Medical Advisory Board |
Olivia Egge | - | 2024 | Member of Patient Advocacy Advisory Board |
Theodore F. Search | 43 | 2020 | Independent Director |
Doug S. Hawkins | - | - | Member of Scientific & Medical Advisory Board |
Peter M. Anderson | - | - | Member of Scientific & Medical Advisory Board |
Karim Galzahr | 51 | 2025 | Independent Director |
Avril Suzette McKean-Dieser | 63 | 2024 | Independent Director |
McHenry T. Tichenor | 70 | 2024 | Member of Patient Advocacy Advisory Board |
Borys Shor | - | 2024 | Member of Antibody Drug Conjugate (ADC) Advisory Board |
Tony Trent | - | 2024 | Member of Patient Advocacy Advisory Board |
Olivier R. Jarry | 44 | 2024 | Independent Director |
Edward J. Robb | - | - | Member of Antibody Drug Conjugate (ADC) Advisory Board |
Miriam Cohen | - | 2024 | Member of Patient Advocacy Advisory Board |
Christopher Benecchi | 53 | - | Member of Antibody Drug Conjugate (ADC) Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review